功能评估简短测试 (FAST):在接受抗抑郁药治疗的大型抑郁症患者中临床上有意义的反应值
Michael Cronquist Christensen1, Simon Nitschky Schmidt1, Iria Grande2
1H. Lundbeck A/S, Valby, Denmark.
Journal of affective disorders
|July 17, 2024
概括
临床医生评估的功能评估简短测试 (FAST) 得分显示,大抑郁症患者的7-9点的减少表明很少有改善. 50%的FAST得分降低表明对抗抑郁药治疗的功能反应.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 神经科学是一个神经科学.
背景情况:
- 功能障碍是被诊断患有严重抑郁症 (MDD) 的患者的一个重要问题.
- 功能评估简短测试 (FAST) 是临床医生评级的工具,用于评估日常生活的功能.
- 确定FAST的临床相关门对于评估抗抑郁药治疗疗效至关重要.
研究的目的:
- 在接受抗抑郁药物治疗的MDD患者中确定FAST的临床相关响应值.
- 验证FAST作为MDD功能改善的衡量标准.
主要方法:
- 来自三项为期8周的临床试验的数据分析,涉及使用抗抑郁药物治疗的MDD患者.
- 使用基于的方法来定义FAST总得分的临床重要差异最小值 (MCID) 和响应值.
- 在试验中,通过FAST作为预先指定的终点来评估功能.
主要成果:
- 经过8周的抗抑郁药治疗,患者的FAST总得分平均降低了7-9分 (约20%),临床改善最小 (CGI-I得分为3).
- 在FAST总得分下降16-19分 (约50%),被确定为功能反应的门 (CGI-I得分≤2).
- 与单独患有MDD的患者相比,患有MDD和并发性泛性焦虑症的患者表现出更高的功能响应值 (26分,63%的减少).
结论:
- FAST已被验证用于评估MDD患者的功能.
- 作为MCID,建议将FAST总得分降低7-9分.
- 与基线相比,FAST总得分的减少约为50%,被建议作为MDD.功能响应的门.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Depressive Disorders: MDD and Dysthymia
90
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
90


